Which has preferable valuation and earnings, NSPR or CVRX?

InspireMD has higher earnings, but lower revenue than CVRx. CVRx is trading at a lower price-to-earnings ratio than InspireMD, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio InspireMD $10.85M 3.03 -$19.92M -$0.73 N/A CVRx $56.65M 2.41 -$53.31M -$2.02 N/A

Is NSPR or CVRX more profitable?

CVRx has a net margin of -89.14% compared to InspireMD's net margin of -413.96%. InspireMD's return on equity of -69.42% beat CVRx's return on equity. Company Net Margins Return on Equity Return on Assets InspireMD -413.96% -69.42% -57.68% CVRx -89.14% -120.76% -48.38%

Does the media prefer NSPR or CVRX?

In the previous week, InspireMD had 1 more articles in the media than CVRx. MarketBeat recorded 2 mentions for InspireMD and 1 mentions for CVRx. InspireMD's average media sentiment score of 0.33 beat CVRx's score of 0.00 indicating that InspireMD is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment InspireMD 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral CVRx 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has preferable earnings and valuation, NSPR or SNWV?

Sanuwave Health has higher revenue and earnings than InspireMD. InspireMD is trading at a lower price-to-earnings ratio than Sanuwave Health, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio InspireMD $10.85M 3.03 -$19.92M -$0.73 N/A Sanuwave Health $44.05M 1.60 $11.81M $0.33 24.85

Is NSPR or SNWV more profitable?

Sanuwave Health has a net margin of 35.96% compared to InspireMD's net margin of -413.96%. InspireMD's return on equity of -69.42% beat Sanuwave Health's return on equity. Company Net Margins Return on Equity Return on Assets InspireMD -413.96% -69.42% -57.68% Sanuwave Health 35.96% -450.56% 44.87%

Is NSPR or NNOX more profitable?

InspireMD has a net margin of -413.96% compared to Nano-X Imaging's net margin of -790.87%. Nano-X Imaging's return on equity of -64.65% beat InspireMD's return on equity. Company Net Margins Return on Equity Return on Assets InspireMD -413.96% -69.42% -57.68% Nano-X Imaging -790.87% -64.65% -57.27%

Does the media refer more to NSPR or NNOX?

In the previous week, Nano-X Imaging had 21 more articles in the media than InspireMD. MarketBeat recorded 23 mentions for Nano-X Imaging and 2 mentions for InspireMD. InspireMD's average media sentiment score of 0.33 beat Nano-X Imaging's score of -0.06 indicating that InspireMD is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment InspireMD 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Nano-X Imaging 1 Very Positive mention(s) 2 Positive mention(s) 19 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media favor MBOT or NSPR?

In the previous week, Microbot Medical and Microbot Medical both had 2 articles in the media. Microbot Medical's average media sentiment score of 0.67 beat InspireMD's score of 0.33 indicating that Microbot Medical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Microbot Medical 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive InspireMD 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Is RCEL or NSPR more profitable?

Avita Medical has a net margin of -62.67% compared to InspireMD's net margin of -413.96%. Avita Medical's return on equity of 0.00% beat InspireMD's return on equity. Company Net Margins Return on Equity Return on Assets Avita Medical -62.67% N/A -78.92% InspireMD -413.96% -69.42% -57.68%

Does the media prefer RCEL or NSPR?

In the previous week, InspireMD had 1 more articles in the media than Avita Medical. MarketBeat recorded 2 mentions for InspireMD and 1 mentions for Avita Medical. InspireMD's average media sentiment score of 0.33 beat Avita Medical's score of 0.00 indicating that InspireMD is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Avita Medical 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral InspireMD 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

InspireMD (NSPR) Competitors

$0.70 -0.02 (-2.11%)

Closing price 04:00 PM Eastern

Extended Trading

$0.72 +0.02 (+2.57%)

As of 07:45 PM Eastern

Compare

NSPR vs. CVRX, SNWV, NNOX, MBOT, and RCEL

Should you buy InspireMD stock or one of its competitors? MarketBeat compares InspireMD with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with InspireMD include CVRx (CVRX), Sanuwave Health (SNWV), Nano-X Imaging (NNOX), Microbot Medical (MBOT), and Avita Medical (RCEL). These companies are all part of the "medical equipment" industry.

How does InspireMD compare to CVRx?

InspireMD (NYSE:NSPR) and CVRx (NASDAQ:CVRX) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, profitability, institutional ownership, dividends, risk, earnings, analyst recommendations and valuation.

InspireMD currently has a consensus price target of $4.50, suggesting a potential upside of 541.94%. CVRx has a consensus price target of $11.50, suggesting a potential upside of 123.30%. Given InspireMD's higher possible upside, equities research analysts plainly believe InspireMD is more favorable than CVRx.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
InspireMD	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00
CVRx	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	2 Strong Buy rating(s)	3.00

CVRx has a net margin of -89.14% compared to InspireMD's net margin of -413.96%. InspireMD's return on equity of -69.42% beat CVRx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
InspireMD	-413.96%	-69.42%	-57.68%
CVRx	-89.14%	-120.76%	-48.38%

InspireMD has a beta of 0.74, suggesting that its stock price is 26% less volatile than the broader market. Comparatively, CVRx has a beta of 0.8, suggesting that its stock price is 20% less volatile than the broader market.

In the previous week, InspireMD had 1 more articles in the media than CVRx. MarketBeat recorded 2 mentions for InspireMD and 1 mentions for CVRx. InspireMD's average media sentiment score of 0.33 beat CVRx's score of 0.00 indicating that InspireMD is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
InspireMD	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
CVRx	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

44.8% of InspireMD shares are held by institutional investors. Comparatively, 75.3% of CVRx shares are held by institutional investors. 34.1% of InspireMD shares are held by company insiders. Comparatively, 18.9% of CVRx shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

InspireMD has higher earnings, but lower revenue than CVRx. CVRx is trading at a lower price-to-earnings ratio than InspireMD, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
InspireMD	$10.85M	3.03	-$19.92M	-$0.73	N/A
CVRx	$56.65M	2.41	-$53.31M	-$2.02	N/A

Summary

InspireMD beats CVRx on 10 of the 16 factors compared between the two stocks.

How does InspireMD compare to Sanuwave Health?

InspireMD (NYSE:NSPR) and Sanuwave Health (NASDAQ:SNWV) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, media sentiment, profitability, dividends, analyst recommendations and valuation.

44.8% of InspireMD shares are owned by institutional investors. Comparatively, 42.5% of Sanuwave Health shares are owned by institutional investors. 34.1% of InspireMD shares are owned by insiders. Comparatively, 14.4% of Sanuwave Health shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

InspireMD has a beta of 0.74, meaning that its stock price is 26% less volatile than the broader market. Comparatively, Sanuwave Health has a beta of 1.34, meaning that its stock price is 34% more volatile than the broader market.

In the previous week, InspireMD had 2 more articles in the media than Sanuwave Health. MarketBeat recorded 2 mentions for InspireMD and 0 mentions for Sanuwave Health. InspireMD's average media sentiment score of 0.33 beat Sanuwave Health's score of 0.00 indicating that InspireMD is being referred to more favorably in the media.

Company	Overall Sentiment
InspireMD	Neutral
Sanuwave Health	Neutral

InspireMD currently has a consensus target price of $4.50, suggesting a potential upside of 541.94%. Sanuwave Health has a consensus target price of $51.00, suggesting a potential upside of 521.95%. Given InspireMD's stronger consensus rating and higher probable upside, equities research analysts clearly believe InspireMD is more favorable than Sanuwave Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
InspireMD	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00
Sanuwave Health	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50

Sanuwave Health has a net margin of 35.96% compared to InspireMD's net margin of -413.96%. InspireMD's return on equity of -69.42% beat Sanuwave Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
InspireMD	-413.96%	-69.42%	-57.68%
Sanuwave Health	35.96%	-450.56%	44.87%

Sanuwave Health has higher revenue and earnings than InspireMD. InspireMD is trading at a lower price-to-earnings ratio than Sanuwave Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
InspireMD	$10.85M	3.03	-$19.92M	-$0.73	N/A
Sanuwave Health	$44.05M	1.60	$11.81M	$0.33	24.85

Summary

InspireMD beats Sanuwave Health on 9 of the 17 factors compared between the two stocks.

How does InspireMD compare to Nano-X Imaging?

InspireMD (NYSE:NSPR) and Nano-X Imaging (NASDAQ:NNOX) are both small-cap medical equipment companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, dividends, analyst recommendations, earnings, risk, profitability and valuation.

44.8% of InspireMD shares are owned by institutional investors. Comparatively, 21.5% of Nano-X Imaging shares are owned by institutional investors. 34.1% of InspireMD shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

InspireMD has a net margin of -413.96% compared to Nano-X Imaging's net margin of -790.87%. Nano-X Imaging's return on equity of -64.65% beat InspireMD's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
InspireMD	-413.96%	-69.42%	-57.68%
Nano-X Imaging	-790.87%	-64.65%	-57.27%

InspireMD presently has a consensus price target of $4.50, indicating a potential upside of 541.94%. Nano-X Imaging has a consensus price target of $5.00, indicating a potential upside of 231.13%. Given InspireMD's stronger consensus rating and higher probable upside, equities research analysts clearly believe InspireMD is more favorable than Nano-X Imaging.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
InspireMD	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00
Nano-X Imaging	2 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	3 Strong Buy rating(s)	2.83

In the previous week, Nano-X Imaging had 21 more articles in the media than InspireMD. MarketBeat recorded 23 mentions for Nano-X Imaging and 2 mentions for InspireMD. InspireMD's average media sentiment score of 0.33 beat Nano-X Imaging's score of -0.06 indicating that InspireMD is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
InspireMD	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Nano-X Imaging	1 Very Positive mention(s)	2 Positive mention(s)	19 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

InspireMD has a beta of 0.74, indicating that its share price is 26% less volatile than the broader market. Comparatively, Nano-X Imaging has a beta of 1.21, indicating that its share price is 21% more volatile than the broader market.

InspireMD has higher earnings, but lower revenue than Nano-X Imaging. InspireMD is trading at a lower price-to-earnings ratio than Nano-X Imaging, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
InspireMD	$10.85M	3.03	-$19.92M	-$0.73	N/A
Nano-X Imaging	$13.02M	8.07	-$75.02M	-$1.59	N/A

Summary

InspireMD beats Nano-X Imaging on 10 of the 17 factors compared between the two stocks.

How does InspireMD compare to Microbot Medical?

Microbot Medical (NASDAQ:MBOT) and InspireMD (NYSE:NSPR) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, earnings, risk, analyst recommendations, institutional ownership, dividends, media sentiment and valuation.

In the previous week, Microbot Medical and Microbot Medical both had 2 articles in the media. Microbot Medical's average media sentiment score of 0.67 beat InspireMD's score of 0.33 indicating that Microbot Medical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Microbot Medical	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
InspireMD	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Microbot Medical has higher earnings, but lower revenue than InspireMD. Microbot Medical is trading at a lower price-to-earnings ratio than InspireMD, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Microbot Medical	N/A	N/A	-$13.14M	-$0.26	N/A
InspireMD	$10.85M	3.03	-$19.92M	-$0.73	N/A

Microbot Medical presently has a consensus target price of $6.63, indicating a potential upside of 264.01%. InspireMD has a consensus target price of $4.50, indicating a potential upside of 541.94%. Given InspireMD's stronger consensus rating and higher possible upside, analysts clearly believe InspireMD is more favorable than Microbot Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Microbot Medical	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.60
InspireMD	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00

16.3% of Microbot Medical shares are held by institutional investors. Comparatively, 44.8% of InspireMD shares are held by institutional investors. 4.7% of Microbot Medical shares are held by insiders. Comparatively, 34.1% of InspireMD shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Microbot Medical has a beta of 1.04, indicating that its stock price is 4% more volatile than the broader market. Comparatively, InspireMD has a beta of 0.74, indicating that its stock price is 26% less volatile than the broader market.

Microbot Medical has a net margin of 0.00% compared to InspireMD's net margin of -413.96%. Microbot Medical's return on equity of -21.84% beat InspireMD's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Microbot Medical	N/A	-21.84%	-20.71%
InspireMD	-413.96%	-69.42%	-57.68%

Summary

Microbot Medical beats InspireMD on 8 of the 15 factors compared between the two stocks.

How does InspireMD compare to Avita Medical?

Avita Medical (NASDAQ:RCEL) and InspireMD (NYSE:NSPR) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their valuation, earnings, institutional ownership, profitability, dividends, risk, analyst recommendations and media sentiment.

Avita Medical has a net margin of -62.67% compared to InspireMD's net margin of -413.96%. Avita Medical's return on equity of 0.00% beat InspireMD's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Avita Medical	-62.67%	N/A	-78.92%
InspireMD	-413.96%	-69.42%	-57.68%

27.7% of Avita Medical shares are held by institutional investors. Comparatively, 44.8% of InspireMD shares are held by institutional investors. 2.8% of Avita Medical shares are held by insiders. Comparatively, 34.1% of InspireMD shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Avita Medical has a beta of 1.87, meaning that its stock price is 87% more volatile than the broader market. Comparatively, InspireMD has a beta of 0.74, meaning that its stock price is 26% less volatile than the broader market.

In the previous week, InspireMD had 1 more articles in the media than Avita Medical. MarketBeat recorded 2 mentions for InspireMD and 1 mentions for Avita Medical. InspireMD's average media sentiment score of 0.33 beat Avita Medical's score of 0.00 indicating that InspireMD is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Avita Medical	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
InspireMD	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

InspireMD has lower revenue, but higher earnings than Avita Medical. Avita Medical is trading at a lower price-to-earnings ratio than InspireMD, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Avita Medical	$71.61M	1.68	-$48.59M	-$1.57	N/A
InspireMD	$10.85M	3.03	-$19.92M	-$0.73	N/A

Avita Medical currently has a consensus price target of $7.25, suggesting a potential upside of 84.95%. InspireMD has a consensus price target of $4.50, suggesting a potential upside of 541.94%. Given InspireMD's stronger consensus rating and higher possible upside, analysts clearly believe InspireMD is more favorable than Avita Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Avita Medical	1 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.33
InspireMD	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00

Summary

InspireMD beats Avita Medical on 11 of the 15 factors compared between the two stocks.

Get InspireMD News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NSPR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

NSPR vs. The Competition

Export

Metric	InspireMD	Surgical & medical instruments Industry	Medical Sector	NYSE Exchange
Market Cap	$32.83M	$43.19M	$6.45B	$23.27B
Dividend Yield	N/A	1.08%	2.69%	4.07%
P/E Ratio	-0.93	14.77	21.07	28.29
Price / Sales	3.03	27.83	530.36	21.84
Price / Cash	N/A	18.86	44.82	24.45
Price / Book	0.38	8.22	10.79	4.64
Net Income	-$19.92M	-$20.39M	$3.56B	$1.07B
7 Day Performance	-1.60%	-4.09%	1.67%	-1.04%
1 Month Performance	-29.90%	-10.04%	0.43%	0.18%
1 Year Performance	-72.18%	-13.04%	32.84%	24.25%

InspireMD Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
NSPR InspireMD	4.085 of 5 stars	$0.70 -2.1%	$4.50 +541.9%	-70.9%	$32.83M	$10.85M	N/A	50	Gap Up
CVRX CVRx	1.9618 of 5 stars	$4.87 -2.2%	$11.50 +136.1%	-17.1%	$132.15M	$56.65M	N/A	160
SNWV Sanuwave Health	1.9875 of 5 stars	$8.51 -42.0%	$51.00 +499.3%	-73.2%	$126.15M	$44.05M	25.79	40	High Trading Volume
NNOX Nano-X Imaging	3.2628 of 5 stars	$1.72 -5.0%	$5.00 +190.7%	-67.5%	$125.96M	$13.02M	N/A	190	Trending News
MBOT Microbot Medical	2.7494 of 5 stars	$1.82 flat	$6.63 +264.0%	-23.2%	$122.24M	N/A	N/A	20	Gap Up

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:NSPR) was last updated on 6/23/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

InspireMD (NSPR) Competitors

NSPR vs. CVRX, SNWV, NNOX, MBOT, and RCEL

How does InspireMD compare to CVRx?

Summary

How does InspireMD compare to Sanuwave Health?

Summary

How does InspireMD compare to Nano-X Imaging?

Summary

How does InspireMD compare to Microbot Medical?

Summary

How does InspireMD compare to Avita Medical?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

NSPR vs. The Competition

InspireMD Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

InspireMD (NSPR) Competitors

NSPR vs. CVRX, SNWV, NNOX, MBOT, and RCEL

How does InspireMD compare to CVRx?

Do analysts recommend NSPR or CVRX?

Is NSPR or CVRX more profitable?

Which has more risk & volatility, NSPR or CVRX?

Does the media prefer NSPR or CVRX?

Do institutionals and insiders have more ownership in NSPR or CVRX?

Which has preferable valuation and earnings, NSPR or CVRX?

Summary

How does InspireMD compare to Sanuwave Health?

Do insiders and institutionals have more ownership in NSPR or SNWV?

Which has more volatility and risk, NSPR or SNWV?

Does the media refer more to NSPR or SNWV?

Do analysts rate NSPR or SNWV?

Is NSPR or SNWV more profitable?

Which has preferable earnings and valuation, NSPR or SNWV?

Summary

How does InspireMD compare to Nano-X Imaging?

Do insiders & institutionals have more ownership in NSPR or NNOX?

Is NSPR or NNOX more profitable?

Do analysts prefer NSPR or NNOX?

Does the media refer more to NSPR or NNOX?

Which has more volatility and risk, NSPR or NNOX?

Which has preferable valuation & earnings, NSPR or NNOX?

Summary

How does InspireMD compare to Microbot Medical?

Does the media favor MBOT or NSPR?

Which has preferable valuation and earnings, MBOT or NSPR?

Do analysts rate MBOT or NSPR?

Do insiders and institutionals believe in MBOT or NSPR?

Which has more risk and volatility, MBOT or NSPR?

Is MBOT or NSPR more profitable?

Summary

How does InspireMD compare to Avita Medical?

Is RCEL or NSPR more profitable?

Do insiders and institutionals have more ownership in RCEL or NSPR?

Which has more risk and volatility, RCEL or NSPR?

Does the media prefer RCEL or NSPR?

Which has better earnings & valuation, RCEL or NSPR?

Do analysts recommend RCEL or NSPR?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

NSPR vs. The Competition

InspireMD Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools